Olof Gerdur Isberg1,2,3, Yuchen Xiang1, Sigridur Klara Bodvarsdottir3, Jon Gunnlaugur Jonasson4,5, Margret Thorsteinsdottir2,3, Zoltan Takats1. 1. Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom. 2. Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland. 3. Biomedical Center, University of Iceland, Reykjavik, Iceland. 4. Pathology, Landspitali-National University Hospital, Reykjavik, Iceland. 5. Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Abstract
Background: Metabolites, especially lipids, have been shown to be promising therapeutic targets. In conjugation with genes and proteins they can be used to identify phenotypes of disease and support the development of targeted treatments. The majority of clinically collected tissue samples are stored in formalin-fixed and paraffin embedded (FFPE) blocks due to their tissue conservation ability and indefinite storage capacity. For metabolic analysis, however, fresh frozen (FF) samples are currently preferred over FFPE samples due to concerns of metabolic information being lost when preparing the samples. With little or no sample preparation, desorption electrospray ionisation mass spectrometry imaging (DESI-MSI) allows for the study of spatial as well as spectral information. Methods: DESI-MSI analysis was performed on FFPE breast cancer tissue microarray samples from 213 patients collected between the years 1935-2013. Logistic regression (LR) models were built to classify samples based on age and FF samples were used for feature validation. Results: LR models developed on the FFPE samples achieved an average classification accuracy of 96% when predicting their age with a 10-year grouping. Closer examination of the metabolic change over time revealed that the mean signal intensities for the lower mass range (100 - 500 m/z) linearly decrease over time, while the mean intensities for the higher mass range (500 - 900 m/z), remained relatively constant. Conclusions: In our samples, which span over 70 years, sample age has a weak yet quantifiable impact on metabolite content in FFPE samples, while the higher mass range is seemingly unaffected. FFPE samples thus provide an alternative avenue for metabolic analysis of lipids.
Background: Metabolites, especially lipids, have been shown to be promising therapeutic targets. In conjugation with genes and proteins they can be used to identify phenotypes of disease and support the development of targeted treatments. The majority of clinically collected tissue samples are stored in formalin-fixed and paraffin embedded (FFPE) blocks due to their tissue conservation ability and indefinite storage capacity. For metabolic analysis, however, fresh frozen (FF) samples are currently preferred over FFPE samples due to concerns of metabolic information being lost when preparing the samples. With little or no sample preparation, desorption electrospray ionisation mass spectrometry imaging (DESI-MSI) allows for the study of spatial as well as spectral information. Methods: DESI-MSI analysis was performed on FFPE breast cancer tissue microarray samples from 213 patients collected between the years 1935-2013. Logistic regression (LR) models were built to classify samples based on age and FF samples were used for feature validation. Results: LR models developed on the FFPE samples achieved an average classification accuracy of 96% when predicting their age with a 10-year grouping. Closer examination of the metabolic change over time revealed that the mean signal intensities for the lower mass range (100 - 500 m/z) linearly decrease over time, while the mean intensities for the higher mass range (500 - 900 m/z), remained relatively constant. Conclusions: In our samples, which span over 70 years, sample age has a weak yet quantifiable impact on metabolite content in FFPE samples, while the higher mass range is seemingly unaffected. FFPE samples thus provide an alternative avenue for metabolic analysis of lipids.
Authors: Kirill A Veselkov; Lisa K Vingara; Perrine Masson; Steven L Robinette; Elizabeth Want; Jia V Li; Richard H Barton; Claire Boursier-Neyret; Bernard Walther; Timothy M Ebbels; István Pelczer; Elaine Holmes; John C Lindon; Jeremy K Nicholson Journal: Anal Chem Date: 2011-07-05 Impact factor: 6.986
Authors: Jialing Zhang; Clara L Feider; Chandandeep Nagi; Wendong Yu; Stacey A Carter; James Suliburk; Hop S Tran Cao; Livia S Eberlin Journal: J Am Soc Mass Spectrom Date: 2017-02-28 Impact factor: 3.109
Authors: Adriana Leandra Santoro; Rodrigo D Drummond; Israel Tojal Silva; Severino S Ferreira; Luiz Juliano; Pedro H Vendramini; Monique Batista da Costa Lemos; Marcos N Eberlin; Victor Piana Andrade Journal: Cancer Res Date: 2020-01-07 Impact factor: 12.701
Authors: Colin A Smith; Grace O'Maille; Elizabeth J Want; Chuan Qin; Sunia A Trauger; Theodore R Brandon; Darlene E Custodio; Ruben Abagyan; Gary Siuzdak Journal: Ther Drug Monit Date: 2005-12 Impact factor: 3.681
Authors: Andreas Dannhorn; Emine Kazanc; Stephanie Ling; Chelsea Nikula; Evdoxia Karali; Maria Paola Serra; Jean-Luc Vorng; Paolo Inglese; Gareth Maglennon; Gregory Hamm; John Swales; Nicole Strittmatter; Simon T Barry; Owen J Sansom; George Poulogiannis; Josephine Bunch; Richard Ja Goodwin; Zoltan Takats Journal: Anal Chem Date: 2020-07-27 Impact factor: 6.986
Authors: Yarixa L Cintron-Diaz; Mario E Gomez-Hernandez; Marthe M H A Verhaert; Peter D E M Verhaert; Francisco Fernandez-Lima Journal: J Am Soc Mass Spectrom Date: 2022-03-08 Impact factor: 3.262